Analytical Data
-
Gene name
TSPAN9
- Application
-
Alternative Names
NET-5; Tetraspan NET-5
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75954
-
Expression Region
Try107~Ala239
-
Molecular Weight
18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TSPAN9, a member of the tetraspanin family, plays a significant role in various cellular processes, including cell adhesion, migration, and signal transduction. This protein is characterized by its four transmembrane domains and is associated with several membrane proteins, influencing their functional properties. Research into TSPAN9 has garnered attention due to its potential involvement in tumorigenesis and metastasis, suggesting that it may serve as a biomarker or therapeutic target in cancer treatment. Studies have indicated that TSPAN9 can modulate immune responses and may be implicated in the regulation of certain immune cell functions, making it relevant in immunological research as well. Recombinant TSPAN9 (rTSPAN9) protein has been produced to facilitate in-depth studies examining its structure-function relationships and to explore its interactions with other proteins and cellular components. Understanding the molecular mechanisms through which TSPAN9 operates could provide insights into the biological pathways involved in disease progression, particularly in cancer and autoimmune disorders. Furthermore, the availability of recombinant TSPAN9 allows researchers to investigate its potential as a target for drug development, paving the way for novel therapeutic strategies. As research advances, elucidating the specific functions and regulatory mechanisms of TSPAN9 could significantly enhance our understanding of its role in health and disease, thereby contributing to the development of innovative approaches to diagnose and treat related conditions.
